Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-16 3:41 pm Purchase | 13G | RADCOM LTD RDCM | BARCLAYS PLC BCS | 861,020 5.72% | 861,020 (New Position) | View |
| 2024-02-15 09:28 am Purchase | 13G | NABORS ENERGY TRANSITION CORP NETD | BARCLAYS PLC BCS | 1,528,728 5.01% | 1,528,728 (New Position) | View |
| 2024-02-14 6:56 pm Purchase | 13G | ISRAEL ACQUISITIONS CORP ISRL | BARCLAYS PLC BCS | 748,637 5.21% | 748,637 (New Position) | View |
| 2024-02-14 6:44 pm Purchase | 13G | KEZAR LIFE SCIENCES INC KZR | BARCLAYS PLC BCS | 3,828,782 5.27% | 3,828,782 (New Position) | View |
| 2024-02-14 6:24 pm Purchase | 13G | LIBERTY MEDIA CORP DEL COM LIB LLYVK | BARCLAYS PLC BCS | 3,434,464 5.4% | 3,434,464 (New Position) | View |
| 2024-02-14 5:45 pm Purchase | 13G | FOUR LEAF ACQUISITION CORP COM FORL | BARCLAYS PLC BCS | 295,978 5.41% | 295,978 (New Position) | View |
| 2024-02-14 5:31 pm Purchase | 13G | THE GREENROSE HOLDING COMPANY GNRS | BARCLAYS PLC BCS | 982,169 5.55% | 982,169 (New Position) | View |
| 2024-02-14 5:14 pm Purchase | 13G | BRIGHTCOVE, INC BCOV | BARCLAYS PLC BCS | 2,450,283 5.64% | 2,450,283 (New Position) | View |
| 2024-02-14 5:08 pm Purchase | 13G | FEUTUNE LT ACQUISITION CORP CL FLFV | BARCLAYS PLC BCS | 335,000 6.04% | 335,000 (New Position) | View |
| 2024-02-14 5:01 pm Purchase | 13G | OPAL FUELS INC OPAL | BARCLAYS PLC BCS | 2,179,689 7.79% | 137,128 (+6.71%) | View |
| 2024-02-14 4:59 pm Purchase | 13G | CINEMARK HLDGS INC CNK | BARCLAYS PLC BCS | 7,695,410 6.32% | 7,695,410 (New Position) | View |
| 2024-02-14 4:52 pm Purchase | 13G | DUET ACQUISITION CORP DUET | BARCLAYS PLC BCS | 354,200 6.42% | 354,200 (New Position) | View |
| 2024-02-14 4:49 pm Purchase | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | BARCLAYS PLC BCS | 3,411,407 7.09% | 3,411,407 (New Position) | View |
| 2024-02-14 4:37 pm Sale | 13G | HNR ACQUISITION CORP CLASS A C HNRA | BARCLAYS PLC BCS | 425,000 8.34% | -304,200 (-41.72%) | View |
| 2024-02-08 8:32 pm Sale | 13G | BARCLAYS PLC ADS =4 U BCS | Qatar Investment Authority | 420,120,691 2.8% | -379,999,999 (-47.49%) | View |
| 2024-01-25 1:48 pm Sale | 13G | BARCLAYS PLC ADS =4 U BCS | BlackRock Inc. BLK | 1,303,920,163 8.6% | -79,809,943 (-5.77%) | View |
| 2023-02-10 3:09 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 11.09% | 1,299,700 (+21.11%) | View |
| 2023-02-07 2:10 pm Sale | 13G | BARCLAYS PLC ADS =4 U BCS | BlackRock Inc. BLK | 1,383,730,106 8.7% | -18,022,585 (-1.29%) | View |
| 2023-01-30 3:43 pm Purchase | 13G | INTERPRIVATE III FINL PARTNERS IPVF | BARCLAYS PLC BCS | 1,711,085 6.39% | 1,711,085 (New Position) | View |
| 2023-01-30 3:06 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BARCLAYS PLC BCS | 3,402,767 5.05% | 3,402,767 (New Position) | View |